Proteinaceous cysteine protease inhibitors

Area of Science:

• Biochemistry
• Molecular Biology
• Pathology

Background:

• Cysteine protease inhibitors, discovered in the 1960s, regulate crucial physiological processes including protein turnover, development, and brain function.
• Dysregulation of protease-inhibitor balance is implicated in numerous pathologies, including cancer and neurological disorders.
• Proteolysis and protease inhibition are critical in infection pathology and host defense mechanisms.

Purpose of the Study:

• To provide an overview of current knowledge on proteinaceous cysteine protease inhibitors.
• To highlight the biological processes regulated by these inhibitors.
• To focus on pathologies arising from aberrant protease-inhibitor balance and explore potential corrective strategies.

Main Methods:

• This is a review article, synthesizing existing research and knowledge.
• It focuses on analyzing the roles of cysteine protease inhibitors in biological systems.
• The review examines literature concerning diseases linked to protease-inhibitor imbalance.

Main Results:

• Cysteine protease inhibitors are integral to fundamental biological processes.
• Aberrant protease-inhibitor interactions are a key factor in the development of various diseases.
• Recent advancements offer potential therapeutic avenues for correcting these imbalances.

Conclusions:

• Proteinaceous cysteine protease inhibitors play a vital role in maintaining physiological homeostasis.
• Understanding protease-inhibitor dynamics is crucial for addressing diseases like cancer and neurological disorders.
• Emerging research highlights the therapeutic potential of targeting these inhibitors for disease management.